TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03925350 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03058094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03713931 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study NCT00972829 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03979313 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT03000374 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03000374 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01922804 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00523341 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03767335 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03767335 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03767335 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04472793 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00751790 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04523376 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04523376 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03228082 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00486941 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04674865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04674865 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04615000 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02984085 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT04500418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study NCT04500418 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02049450 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03619681 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00609518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03617588 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03617588 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02398344 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00150670 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00928707 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03322735 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT00054574 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03122925 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT03812744 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03812744 — Safety Biomarker (SAF): BDNF
Study NCT00927797 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04096755 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00294775 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT02650752 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01468818 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01801631 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01801631 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02336724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02336724 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02336724 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT02842112 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02842112 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02771652 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02036359 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02936414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02936414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03286712 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01904240 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01904240 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT04556656 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00459901 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02297698 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02297698 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02297698 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01283347 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC18A2 mRNA
Genes: SLC18A2; SVMT; VMAT2
Study NCT01040819 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT02430285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03010709 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00044967 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04020146 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04020146 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03073707 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT00848250 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03516110 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03951389 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03951389 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03085147 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT04554979 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04666805 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00941928 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03539159 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02988141 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01267279 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02909283 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00175994 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02471339 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01989637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00318396 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00790101 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04395066 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT04395066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04395066 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03199885 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01077388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00082758 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03179007 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT03596658 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03596658 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04636047 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT04636047 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04636047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT02865421 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT02459535 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03666650 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00006458 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03478527 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03478527 — Safety Biomarker (SAF): BDNF
Study NCT00421603 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT00418964 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01062568 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03882255 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03882255 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03041909 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03151252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00328965 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01490710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00078520 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00078520 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04626505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04470817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04470817 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03988660 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01759498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01759498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04407208 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02935153 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04223024 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01974713 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02303873 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01595763 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06018012 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT03383978 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00025402 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03722667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004025 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01785810 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04063423 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT03786640 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03936712 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04708574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02258295 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02458287 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02458287 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02515149 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03225716 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01652755 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02632318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01530438 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03610516 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01674569 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01674569 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02838121 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03835676 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01888666 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00587990 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04373486 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03839823 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03839823 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03057418 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03057418 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02489006 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02489006 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT02405884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04012151 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04377880 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study NCT01404078 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02695173 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02820207 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02820207 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03888859 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01199250 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT01199250 — Predictive Biomarker (PRD): EPHB2 mRNA
Genes: EPHB2; DRT; EPHT3; EPTH3; ERK; HEK5; TYRO5
Study NCT01199250 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT01199250 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT03247309 — Predictive Biomarker (PRD): MAGEA4 mRNA
Genes: MAGEA4; MAGE4
Study NCT00123474 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00123474 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01906892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01016886 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04429685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05821153 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01588704 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01588704 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03865368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00681850 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01377376 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01377376 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03259438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03259438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01764256 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04197817 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT00923273 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02820649 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02820649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04744623 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04510051 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04510051 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT03780309 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02113527 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT02819700 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01919853 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study NCT00120978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00120978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03893565 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT00843479 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01544179 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01544179 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02353780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02353780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03125876 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01329900 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00815360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00815360 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02282527 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04782999 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03031756 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02051361 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00447993 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT01299688 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01269333 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00273390 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01464931 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04287335 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04287335 — Predictive Biomarker (PRD): BMP3 mRNA
Genes: BMP3; BMP3A
Study NCT04287335 — Predictive Biomarker (PRD): NDRG4 mRNA
Genes: NDRG4; BDM1; KIAA1180
Study NCT00632294 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04626076 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01784939 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT05188482 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02556229 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02556229 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04170751 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04170751 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02374333 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03906578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01567475 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01603160 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02546427 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00212303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04363437 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02898467 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00747877 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00003450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06027385 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00434512 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02955758 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00111917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00005206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04182724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03004287 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00942019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00942019 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00942019 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT00942019 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00942019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04335786 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT02000453 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01939574 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01939574 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01479166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01479166 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study NCT01479166 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01479166 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01479166 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT00269243 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00734396 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02242617 — Surrogate Endpoint (SUR): Blood pressure